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Abstract
The presence of a DNase activity associated with secretion granules was detected in T4 and T8 lymphocytes from
 .patients with autoimmune diseases. This activity was much higher in primary biliary cirrhosis PBC than in Graves’ disease
 .  . 2qGD and multiple sclerosis MS or in healthy subjects. This granule associated DNase activity was Ca -dependent,
inhibited by Zn2q, and higher at low pH; its molecular weight corresponded to 66 kDa; it was more active with
double-strand than single-strand DNA. Judging from its properties this enzyme differed from the three types of
 .endonucleases described as involved in DNA fragmentation DNase I, DNase II and NUC18 . Flow cytometry analysis of T
lymphocytes showed that DNase activity associated with CD4q lymphocyte granules correlated with the ratio
q q q q  .CD4 CD45RO rCD4 CD45RA memory and cytotoxic cellsrnaive cells, inducers of suppression . In contrast, T8
q q y lymphocyte DNase activity correlated with the proportion of CD4 lymphocytes with CD4 CD45RA phenotype helpers
.and inducers of cytotoxicity . The possible role of this DNase activity in the mechanisms of lysis or apoptosis mediated by
CTL is discussed. We suggest that this DNase activity could be implicated in some of the alterations of the autoimmune
response depending on cytotoxic T lymphocytes or T cell inducers of apoptosis. q 1998 Elsevier Science B.V.
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1. Introduction
Organ-specific autoimmune diseases are character-
ized by abnormal immune responses; the immune
system attacks autologous tissues leading to profound
Abbreviations: PBC, primary biliary cirrhosis; GD, Graves’
disease; MS, multiple sclerosis; HD, healthy donor; CTL, cy-
tolytic T lymphocytes; PBMC, peripheral blood mononuclear
cells; F.I., fragmentation index; DTT, dithiothreitol
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alterations. In some of these diseases, such as pri-
 .mary biliary cirrhosis PBC or multiple sclerosis
 . q qMS , tissue infiltration by both CD8 and CD4 T
lymphocytes, some of them with cytotoxic activity
 .cytotoxic T lymphocytes; CTL , at the organs af-
fected are a common occurrence, and for that reason
considered to be T-cell-mediated autoimmune dis-
w xeases 1–4 . Although autoantibodies against TSH
receptor are crucial in the stimulation of the thyroid
 . w xgland in Graves’ disease GD 5 , intrathyroidal
lymphocytes may also participate in the induction of
w xthyroid disfunction 6,7 . Some authors have sug-
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gested that an imbalance among different T cell
subsets may be an underlying cause leading to au-
w xtoimmunity 8–11 .
Lymphocyte-mediated cytolysis is a multistage
process possibly involved in the destruction of target
cells in a major histocompatibility complex class I
and class II restricted attack with the participation of
w xauxiliary adhesion molecules 12–14 . Two possible
cytocidal mechanisms, not mutually exclusive, proba-
bly associated with different types of CTL, or with
the same effector cell at different stages of differenti-
w xation, have been proposed 13,14 : in the first mecha-
nism, lytic molecules, prepackaged in cytoplasmic
granules are secreted to form lytic pores on the target
cell membrane, whereas in the second mechanism,
interactions between specific cell surface receptors
trigger apoptosis. Cooperation between secreted
granzymes and perforin brings about CTL-induced
lysis, including DNA fragmentation; in addition,
HLA-II restricted perforin-negative CD4q CTLs
w xcould also be responsible for this lysis 14 . A 15 kDa
cytoplasmic granule associated protein, the T cell-re-
 .stricted intracellular antigen TIA-1 , mainly associ-
ated with a subpopulation of CD8q T lymphocytes
and scarcely present, or not present at all, in CD4q
w xresting T lymphocytes has been described 15 . How-
ever, it has been recently described that CD4q CTLs
simultaneously induce apoptosis of target cell nuclei
and membrane damage; CD4q clones synthesize per-
forin and granzyme B and express the granule associ-
w xated protein TIA-1 16 , indicating that two distinct
mechanisms may contribute to cytolysis by CD4q
clones: a Ca2q-dependent mechanism associated with
cytotoxic granules and a Ca2q-independent mecha-
nism. TIA-1, expressed preferentially on cells with
cytolytic potential, has been found to induce DNA
fragmentation in digitonin permeabilized thymocytes,
suggesting that this antigen might be the granule
component responsible for triggering apoptosis in
w x w xtarget cells 17 . It has also been reported 18 that in
inflammatory muscle diseases of autoimmune origin
a chronic lymphocyte infiltration is always present
around the muscles damaged. Cytotoxic cells can
induce target cell death by the two mechanisms men-
tioned above. Granzyme B, perforin and TIA-1 pro-
tein were expressed simultaneously on muscle sam-
ples from patients with polymyositis, suggesting that
cytotoxic cells can cause muscle damage and muscle
necrosis andror apoptosis by releasing proteins re-
w xsponsible for the lysis of target cells 18 .
We have already reported the expression of DNase
activity associated with cytoplasmic granules on acti-
vated CD4q lymphocytes after the incubation of
PBMC from healthy subjects in the presence of im-
w xmunomodulating peptides 19 . A number of endonu-
cleases have been described in a variety of cells,
some of them related to DNA fragmentation in apop-
w xtosis 20–22 . The induction of this activity in human
q w xactivated CD4 lymphocytes 19 and the participa-
w xtion of T cells in autoimmune diseases 1–4 prompted
us to explore the possible presence of granule associ-
ated DNases in T lymphocytes obtained from patients
with autoimmune diseases. We report now the exis-
tence of a DNase activity associated with cytoplasmic
granules in CD4q and CD8q lymphocytes from pa-
tients with this type of diseases. This acidic DNase of
66 kDa, activated by Ca2q and inhibited by Zn2q,
required double-strand DNA as substrate. The corre-
lation of this activity with different T cell subsets
suggests that this enzyme activity could be involved
in the immunological alterations observed in autoim-
mune diseases mediated by CTL activity.
2. Materials and methods
2.1. Subjects
All patients with clinically defined PBC, MS or
GD included in this report are part of a follow-up
study being carried out at the University Clinic of the
 .University of Navarra Spain . We studied 10 patients
with PBC femalermale: 8r2; age " standard devia-
.  .tion: 53"13 , 10 patients with MS 7r3; 43"9 , 10
 . with GD 9r1; 47"9 , and 15 healthy donors 9r6;
.39"15 . Patients were randomly selected with the
purpose of finding individuals in different stages of
each of these diseases. 7 PBC patients were in stage I
and 3 in stage IV. 6 of the MS patients were in an
active phase, and in the remaining 4 the disease was
stabilized and had no exacerbation for at least 3
months before the beginning of the study. All of the
GD patients studied had circulating thyroid antibod-
ies and high levels of T4 at the moment of blood
sampling.
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2.2. Isolation of lymphocytes
PBMC were isolated from heparinized venous
blood by Ficoll–Hypaque density gradient. CD4q
and CD8q lymphocytes were separated from 3=107
PBMC after incubating the whole PBMC population
with magnetizable polystyrene beads coated with a
primary mononuclear antibody for CD4 or CD8
 . qmembrane antigen Dynal, Oslo, Norway . CD4
lymphocytes were obtained from 15 healthy donors
 .HD , 7 PBC patients, 5 MS patients, and 5 GD
patients; CD8q lymphocytes from 15 HD, 9 PBC
patients, 5 Ms patients and 8 GD patients.
2.3. Extraction of granule proteins
The isolation of secretion granules was carried out
using a Percoll density-gradient after disrupting the
cells with a Parr nitrogen bomb. Granule proteins
were extracted following the procedure of Podack et
w xal. 23 .
2.4. Detection of DNase acti˝ity
Detection of DNase activity in protein extracts was
performed by the ability to degrade genomic DNA.
The extracted granule proteins corresponding to 3=
107 PBMC were incubated with 10 mg of protein free
DNA at 378C for 24 h in 50 ml of a 50 mM NaCl,
 .10 mM MgCl , 1 mM dithiothreitol DTT , 10 mM2
Tris–HCl autoclaved buffer, pH 7.5. Some incuba-
tions were performed without the addition of DTT.
When testing at pH values other than 7.5, the follow-
 .ing buffers were used: sodium acetate pH 5 , MES
 .  .  .pH 6 , MOPS pH 7 or HEPES pH 8 all of them
at 10 mM. An aliquot of 20 ml of the resulting mix-
ture was applied to a 1% agarose gel, and subjected
to electrophoresis at a voltage of 50 V in 1 mM
EDTA, 40 mM Tris–HCl buffer, pH 7.5, containing
0.5 mg of ethidium bromide per ml. Genomic DNA
w xwas obtained as described in the literature 24 . To
quantify and compare the results obtained in different
experiments, we carried out a simple image analysis
with the appropriate software Image Master, Phar-
.macia . Electrophoregrams on gels were photo-
graphed and images scanned and inverted. Each lane
was divided into three sectors, using as reference a
molecular weight marker HindIII-digested l phage
.DNA, Promega loaded in parallel to the samples of
each gel. Sector A corresponded to the 23 Kb first
band of the marker and contained the undigested
DNA; sector B extended from the lower limit of
sector A to the top of the 2.3 Kb band of the marker,
and contained DNA partially degraded in fragments
larger than 2.3 Kb; sector C extended from the lower
limit of sector B to the end of the lane and contained
DNA degraded in fragments smaller than 2.3 Kb. The
programme integrates the absorbance of each sector
and compares it with the total absorbance of each
lane taken as 100%. This allows us to compare
samples run on different gels, and calculate a ‘‘frag-
  . mentation index’’ F.I. % s1r2 B %DNA)
.  ..2.3 Kb qC %DNA-2.3 Kb . In each case, a di-
gestion in DNase free medium was performed in
parallel to calculate the spontaneus degradation which
was subtracted from F.I.
2.5. DNase detection in DNA–SDS-PAGE
Protein electrophoresis was carried out following
w xthe technique of Laemmli and Favre 25 . Separating
 .gels 12% acrylamide–bisacrylamide 37.5r1 were
prepared with the addition of calf thymus DNA
10 mgrml. Protein extracts were mixed with sample
loading buffer 0.125 M Tris–HCl, pH 6.4, 4% SDS,
20% glycerol, 10% b-mercaptoethanol and 0.01%
.bromophenol blue and heated at 378C for 20 min
before being placed in the wells. Following elec-
trophoresis, gels were washed three times in distilled
water, once in 40 mM Tris–HCl, pH 7.6, 2 mM
MgCl , 1 mM EDTA and twice again in distilled2
water. Each wash was prolonged for 10–12 min in
order to ensure the removal of SDS and b-mercapto-
ethanol. Incubation was continued in 10 mM Tris–
HCl, pH 7.6, 50 mM NaCl, 1 mM CaCl , 10 mM2
MgCl , 1 mM DTT. Experiments were also carried2
out in the absence of DTT. After 4 h ethidium bro-
 .mide 1 mgrml was added to the gel incubation
buffer. After 30 min gels were examined under UV
light and photographed. The positions of DNase ac-
tivity were revealed as dark bands on a fluorescent
background.
2.6. Analysis of lymphocyte subpopulations
Phenotypic characterization of T cells was carried
out using an EPICS Profile-II flow cytometer Coulter
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.Electronics, Hialeah, FL, USA . The monoclonal an-
tibodies used in this work were supplied by Becton–
Dickinson Becton-Dickinson Immunocytometry Sys-
.tems, Erembodegen, Belgium . Analysis of mem-
brane determinant co-expression using double-colour
 .combinations Fluorescein and Phycoerythrin was
done following the manufacturer’s instructions. To
determine TIA-1 antigen in human lymphocytes
murine macrophage IgG1 anti-TIA-1 was used
 . 5Coulter Electronics, Hialeah, FL, USA . 5=10
lymphomononuclear cells were fixed with cold 4%
paraformaldehyde for 20 min, then washed with PBS
containing 0.1% sodium azide and suspended in 50 ml
of permeabilization buffer PBS with 0.1% sodium
.azide, 1% heat-inactivated FCS and 0.1% saponin .
Cells were incubated with anti-TIA-1 antibody at 48C
for 45 min, and washed with permeabilization buffer.
Cells were then incubated again for 30 min in the
presence of rat antibody against murine IgG1 conju-
gated with phycoerithrin. After washing them with
permeabilization buffer, cells were suspended in PBS
and analyzed by flow cytometry. The expression of
TIA-1 on T4 or T8 lymphocytes was analyzed using
double color analysis.
2.7. Statistical analysis
The values obtained from cytometry were analyzed
by U Mann-Whitney test to compare data between
groups of subjects. Correlations were analyzed by the
Spearman test. A p value less than 0.05 was consid-
ered to be significant.
3. Results
3.1. DNase acti˝ity in cytoplasmic granules of CD4q
and CD8q T cells
Protein extracts from secretion granules corre-
sponding to T4 and T8 lymphocytes isolated from
q  . qFig. 1. DNase activity in granules of CD4 cells from PBC, MS, GD and healthy donors. A DNase activity from CD4 cells expressed
 .  .as ‘fragmentation index’ F.I. . All the individual values are represented together with the mean "S.D. for each group studied. B
Electrophoregram reflecting DNase activity extracted from granules present in CD4q cells. For each group a representative example is
given. Lane 1, Standard DNA. Lane 2, DNA incubated with DNase-free medium. Lanes 3, 4, 5 and 6, DNA fragmentation induced by
DNase present in CD4q cells from a healthy donor, or from PBC, MS and GD patients, respectively.
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q  . qFig. 2. DNase activity in granules of CD8 cells from PBC, MS, GD patients and healthy donors. A DNase activity from CD8 cells
 .measured as ‘‘fragmentation index’’ F.I. . All the individual values are represented together with the mean "S.D. for each group
 . qstudied. B Electrophoregram reflecting DNase activity present in granules of CD8 cells. For each group a representative example is
given. Lane 1, Standard DNA. Lane 2, DNA incubated with DNase-free medium. Lanes 3, 4, 5 and 6, DNA fragmentation induced by
DNase present in CD8q cells from a healthy donor, or from PBC, MS and GD patients, respectively.
3=107 fresh PBMC belonging to patients or healthy
donors were incubated with protein-free genomic
DNA for 24 h. Then DNase activity was determined
analyzing DNA fragmentation by electrophoresis on
agarose gel. A higher DNase activity, expressed as
 .‘‘fragmentation index’’ F.I. , was found both in
q  . q  .CD4 Fig. 1 and CD8 cells Fig. 2 from patients
when compared to HD; ps0.0431 and ps0.0459,
respectively. The highest values were found in PBC
patients. In some GD patients a high DNase activity
was also found; although the average of all the values
of DNase activity was not higher than in HD, individ-
ual variability was very wide, perhaps reflecting dif-
ferent immunological situations typical of this dis-
ease. In MS patients the F.I. values were similar to
those found in HD.
3.2. Properties of the DNase enzyme
DNase activity, both in CD4q and CD8q cells,
increased when Ca2q was present in the medium at
pH 7.5. Fig. 3 shows the fragmentation of DNA in a
representative experiment using CD4q cells as source
for the enzyme. This experiment was repeated seven
times with CD4q and CD8q cells belonging to dif-
ferent subjects, and in all cases the activity was
highest with 1 mM Ca2q; increasing Ca2q concentra-
tion to 10 mM inhibited enzyme activity. The addi-
tion of 1 mM Zn2q led to inhibition of the activity,
even when 10 mM Ca2q was present. DNA fragmen-
tation was also measured in the absence of Ca2q at
 .pH 8, 7.5, 7, 6, and 5 Fig. 4 . DNase activity
associated with granules of CD4q or CD8q cells
from different subjects increased with acidification of
the medium; in all cases the activity was up to three
times higher at pH 5 than at pH 8. In the absence of
the enzyme and at the indicated pH values no sponta-
neous degradation of DNA was observed; however,
at pH 4.7 DNA spontaneous degradation took place,
and testing with the enzyme was not performed under
 .those conditions. Fig. 4 A shows the DNA fragmen-
tation effected by CD4q cell granule associated
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Fig. 3. Cation dependence of DNase. Protein extracts were
incubated with genomic DNA for 12 h in 10mM Tris–HCl, pH
7.5, 10mM MgCl , 50 mM NaCl and the corresponding concen-2
trations of divalents cations. Results are expresed as ‘‘fragmenta-
 .tion index’’ F.I. and correspond to a representative result of
seven independent experiments. ) DNA incubated in buffer with
2q optimal concentration of Ca but without protein extract nega-
.tive control .
 .DNase from a GD patient. Fig. 4 B shows the effect
of pH on a DNase activity belonging to CD4q cells
from a PBC patient; in view of the high activity of
that extract, when tested at pH 7.5, the incubation
  ..  .period was limited to 12 h Fig. 4 B . Fig. 4 C
shows the DNA fragmentation at low pH values with
protein extracts of granules obtained from CD8q
lymphocytes belonging to a MS patient. Since the
medium used to detect the DNase activity contained
DTT, we checked the possibility that this reducing
agent might affect the enzyme under study, as it is
the case with other DNases. No changes in the DNase
activity from CD4q or CD8q cells granules were
observed if incubations were carried out in the ab-
sence of DTT at pH 7.5 or pH 5. It was also seen that
in the absence of this reducing agent this DNase
activity was Ca2q-dependent. Therefore, this granule
associated DNase activity from CD4q and CD8q
cells was Ca2q-dependent, inhibited by Zn2q, and
higher at low pH.
To find out whether different DNases were present
in protein extracts from granules belonging to T
lymphocytes and in order to determine their molecu-
lar weights, nucleases were visualized on the gels
w xwith the SDS-PAGE technique 26 . Protein extracts
from secretion granules or from granule-free cytosol
fraction belonging to T lymphocytes were separated
by SDS-PAGE in gels containing DNA. After incu-
bating in an appropriate buffer, spots with DNase
activity appear as dark bands on a flourescent back-
ground when ethidium bromide is added and gels are
placed under UV light. A commercial 31 kDa DNase
 .I Sigma, St.Louis, Missouri was used as reference
control, and protein standards Dalton Mark III L,
.Sigma as molecular weight reference. Photographs
of gels, after the electrophoresis of granule and gran-
ule-free cytosol extracts from CD4q lymphocytes
belonging to a GD patient, are presented in Fig. 5.
Identical results were obtained with a series of equiv-
alent extracts of CD4q or CD8q from 7 different
patients. When native double-strand DNA was used
  ..as substrate Fig. 5 A , one band of approximately
66 kDa appeared both with granule or granule-free
 .cytosol extracts lanes 1 and 2 ; a 31 kDa commercial
DNase I, used as reference, was loaded on lane 3.
However, a drastic decrease in the intensity of the
bands was observed at the location corresponding to
  ..the 66 kDa DNase Fig. 5 B when denatured DNA
 .previously heated at 1008C for 10 min was present
in the gel; under these conditions a new band ap-
peared at approximately 31 kDa in the lane of the
 .granule-free cytosolic extract lane 2 ; an intense
band was also visible at the location of the commer-
 .cial DNase used as reference lane 3 . Therefore, the
electrophoresis showed that granules contained a
66 kDa DNase preferentially fragmenting double-
strand DNA, whereas they lacked the 31 kDa DNase,
preferentially fragmenting single-strand DNA, which
appeared in the granule-free cytosolic extract. Identi-
cal results were obtained when DTT was not added to
the incubation medium used to carry out the DNase
reaction on the gel.
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Fig. 4. Effect of pH on granule associated DNase. Protein extracts were incubated with genomic DNA in 10 mM MgCl , 50 mM NaCl2
and the corresponding buffers at the indicated pH values. DNA fragmentation is representative of 10 independent experiments. DNA
 .incubated at the indicated pH values without protein extract was used as negative control. A Granule DNase from T4 cells belonging to
a GD patient incubated for 24 h. Lane 1, Standard DNA; Lanes 2 and 3, DNA incubated in pH 8 and 5 buffers respectively; Lanes 4–7,
 .DNA incubated with protein extract at pH 5, 6, 7 and 8 respectively. B Granule DNase from T4 cells belonging to a PBC patient
incubated for 12 h. Lanes 1 and 2, DNA incubated in pH 5 and 4.7 buffers respectively; Lanes 3–5, DNA incubated with protein extract
 .at pH 8, 6 and 5. Lane, Standard DNA. C Granule DNase from T8 cells belonging to a MS patient incubated for 24 h. Lanes 1, 3 and 5,
DNA incubated in pH 5, 6 and 7.5 buffers respectively. Lanes 2, 4 and 6 DNA incubated with protein extract in pH 5, 6 and 7.5 buffers
respectively.
Fig. 5. DNase detection in SDS-PAGE. Protein extracts from granules or cytosol belonging to T lymphocytes with DNase activity were
 .  .  .run in gels containing double-strand A or single-strand DNA B . Lane 1, granule protein extract 20 mg ; Lane 2, cytosolic protein
 .  .extract 20 mg ; Lane 3, reference DNase I 0.5 mg .
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Table 1
Mononuclear cell subpoblations in PBC, MS, GD and healthy donors
Cell population HD PBC MS GD
q .CD4 %PBMC 37"10 32"13 29"15 47"8
q .CD8 %PBMC 20"3 15"10 14"7 17"6
q q q a a .CD4 CD45RA % of CD4 45"8 20"6 30"9 54"14
q q q .CD4 CD45RO % of CD4 38"16 42"21 38"16 31"9
q q q a .CD8 CD11b %of CD8 33"10 42"13 53"12 34"11
q q q q aCD4 CD45RO rCD4 CD45RA 0.9"0.5 2.5"1.1 1.3"0.7 0.8"0.4
Results are expressed as percentage of positive cells for the indicated surface markers.
a Significantly different from control.
3.3. Phenotype of T subsets and its correlation with
DNase acti˝ity
Table 1 summarizes the results obtained by pheno-
typic analysis of PBMC from subjects of the 4 groups
studied. Several differences in the functional T cell
subsets from patients were observed when compared
with those present in healthy donors. In PBC and MS
the proportion of CD4q cells with CD4qCD45RAq
phenotype, naive cells whose major immunoregula-
tory function involves suppression, was significantly
lower than that found in healthy controls. In GD the
proportion of CD4q within the PBMC population
was strikingly high; therefore, the number of
CD4qCD45RAq lymphocytes, corresponding to
naive supressor cells, as well as the number of
CD4qCD45RAy lymphocytes, corresponding to
helper cells inducers of cytotoxicity, were higher than
in healthy donors. T he proportion of
CD4qCD45ROq, memory and cytotoxic cells, within
the CD4q cells population was slightly higher in
PBC and lower in GD; the number of CD4q within
Fig. 6. Correlation between CTL granule DNase activity and CD4q subsets from peripheral blood. All the values corresponding to the
 .  .  .  .  .different patients of each disease are represented: v PBC, ‘ MS, q GD. In the case of healthy donors HD , symbol = indicates
 .  . qthe mean of fifteen different individuals. A Correlation ps0.008 between DNase activity associated with granules from CD4 cells
q q q q  .  .and the ratio CD4 CD45RO rCD4 CD45RA . B Correlation ps0.02 between DNase activity from granules of CD8. DNase
 .activity is expressed as fragmentation index F.I. as defined in Section 2
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the entire PBMC population was practically identical
in PBC, GD and healthy donors, while it was slightly
reduced in MS patients.
The differences in DNase activity and lymphocyte
phenotype observed prompted us to look for possible
correlations. We found that there was a direct correla-
tion between the ratio of CD4qCD45ROq
rCD4qCD45RAq and DNase activity in T4 gran-
  ..ules Fig. 6 A . This result is consistent with func-
tions associated with T4 cell subsets: cytotoxic activ-
ity with CD4qCD45ROq memory cells and induc-
tion of suppression with CD4qCD45RAq cells. When
CD8q DNase activity was analyzed, a correlation
between this activity and the percentage of
q -   ..CD4 CD45RA cells Fig. 6 B and between IL-2
q  .secreted by these CD4 helper cells data not shown
was observed. These results are in agreement with the
role of helper CD4CD45RAy cells as cytotoxic-in-
ducers of CD8q and helper cells. In contrast, no
correlation was found between DNase activities of T4
or T8 cells and the different T8 subsets.
In the 3 groups of patients the percentage of CD8q
within PBMC was slightly lower than that observed
in healthy donors. However, in the patients with MS
or PBC a selective enrichment in CD8qCD11bq
lymphocytes, suppressor cells, within the CD8q pop-
ulation was observed. On the other hand, the number
of CD8qCD11by, cytotoxic T8 lymphocytes, was
lower in MS patients. Preliminary results obtained in
our laboratory show that a small proportion of CD4q
 .cells expressed TIA-1 approximately 10% , in con-
trast with the high proportion of CD8q which ex-
pressed this antigen. This proportion was especially
 .high in MS patients 70% .
4. Discussion
The present report shows for the first time that
both CD4q and CD8q lymphocytes from patients
with PBC, and some with GD, contain proteins with
 .DNase activity in secretion granules Figs. 1 and 2 .
This granule associated DNase corresponded to a
2q  .Ca dependent 66 kDa protein Fig. 3 more active
 .at acid pH Fig. 4 , and also more active when
double-strand DNA was used as substrate incorpo-
  ..rated to the gel Fig. 5 A ; it was, therefore, differ-
ent from a 31 kDa DNase I, which was more active
  ..with single-strand DNA Fig. 5 B ; it was also dis-
tinguishable from other nucleases described as Type
II DNases judging by its molecular weight or inhibi-
2q w xtion by Zn ions 27,28 .
Although the function of this DNase activity linked
to lymphocytic granules is not yet clear, our data
suggest that it might be another cytolytic factor; this
would be in agreement with the idea that the expres-
sion of enzymes contained in secretion granules could
be associated with the cytolytic capacity of T cells
w x29 , and with the idea that the cytolytic mechanism
of CTL could be related to an active transfer of a
DNA fragmenting cytotoxic factor into target cells
w x30 . A possible involvement of the DNase activity,
now being described, not only in the DNA fragmenta-
tion induced by CTL on target cells, but also in the
apoptosis of CTL themselves, could be suggested.
This idea is consistent with the observation that an
increase in DNA fragmentation takes place in thymo-
cytes, in parallel with an increase in calcium ions and
w xchelation of intracellular zinc 31–33 , or in CTL, as
w xa consequence of intracellular acidification 34 . Fur-
thermore, CD8q CTL granule components, such as
the TIA-1 RNA-binding proteins, have been de-
scribed as part of a molecular cascade involved in
w xFas-mediated apoptosis 35,36 .
On the other hand, it has been reported that CD4q
cytotoxic T cells induce apoptosis of HLA-II APCs
w x37,38 , and it has been suggested that these cytotoxic
cells could be involved in a direct destruction of
target tissues because of the aberrant expression of
HLA-II on the affected cells in autoimmune diseases
w x39–41 . Our results show that granule associated
DNase both in CD4q and CD8q cells was enhanced
in patients with PBC. This is consistent with a possi-
ble participation of infiltrating CTLs in the destruc-
tion of biliary ducts. DNase activity was lower in the
GD patients studied than in the patients with PBC,
possibly indicating a much deeper immunoregulatory
disturbance in this latter disease. DNase activity was
much lower in the MS patients studied, an observa-
tion consistent with the phenotype of their circulating
lymphocytes: a low CD4qCD45ROqrCD4q
CD45RAqratio and a low proportion of CD4q-
CD45RAy.
It has been described that in autoimmune diseases
an imbalance between cytotoxic cells or inducers of
. cytotoxicity versus suppressors or inducers of sup-
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. w x w xpression occurs 8–11 , 42,43 . Our data are also
consistent with this idea. CTL cytotoxicity present in
the patients studied and manifested by the presence
 .of granule associated DNase Figs. 1 and 2 could be
due to an imbalance between activation of cytotoxic-
ity and induction of suppression. Cytotoxic capacity
of T4 cells, although not fully understood, is com-
monly associated with cells sharing the CD45ROq
memory phenotype, and that of T8 cells with the
y w xCD11b phenotype 44–46 . The correlation between
CD4q DNase activity with the ratio of memory cells
 q q.with cytotoxic potential CD4 CD45RO to induc-
 q q.ers of suppression CD4 CD45RA , shown on Fig.
 .6 A , prompts us to suggest that the appearance of
cytotoxic T4 lymphocytes could be due to a differen-
tiation of CD45RAq cells, inducers of suppression,
into CD45RAy cells, helpers and inducers of cyto-
toxicity, thus modifying the normal inmune home-
ostasis permitting existing memory cells to develop
their cytolytic potential. In agreement with this, no
increase in the number of CD4qCD45ROq cells was
observed even in cases when DNase activity was
higher than usual. Moreover, it has been described
that a loss in cells with suppressor–inducer function
might contribute to the disease process by allowing
the immune response to proceed without feedback
w xsuppression 47 . In PBC, where we found the highest
DNase activity, the CD4qrCD8q cell ratio was 2.5,
a value much higher than that of 0.9 usually found in
healthy individuals. The increase in cytotoxicity could
be explained by the small number of CD4qCD45RAq
 .cells Table 1 . Besides, in the case of PBC the
proportion of CD4qCD45RAy cells, inducers of cy-
totoxicity, within the CD4q lymphocyte population
amounted to about 80%, against a 45% in healthy
controls, figures easily calculated from data in Table
1. This fact is consistent with the high DNase activity
in CD8q lymphocyte granules in PBC, corroborating
the correlation observed between such an activity and
y   ..the CD4CD45RA subset Fig. 6 B . Similarly, in
those GD patients with detectable DNase activity
both in T4 and T8 granules the CD4qCD45ROq
rCD4qCD45RAq ratio as well as the proportion of
CD4qCD45RAy within the CD4q cell population
were higher than in those cases when DNase activity
 .was not detected Fig. 6 .
We suggest that the DNase present in T4 and T8
cell granules, which we have seen to be associated
with an imbalance of cytotoxicity versus suppression
in lymphocytes from patients, plays a role in the
underlying mechanisms operating in autoimmune dis-
eases, possibly through an increase in the cytolytic
potential of T lymphocytes.
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